Eledon Pharmaceuticals
Price & Volume
Stats
See more52W Range | $1.35-$4.60 |
Market Cap | $218.5M |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.90 |
News
See moreYahoo Finance • 2 days ago
Eledon rises on new mid-stage trial data, FDA fast track status for lead drug
Yahoo Finance • 2 months ago
A Diabetes Therapy Just Locked In Its Cell Supplier, and the Race to End Insulin Injections Is Heating Up
Yahoo Finance • 3 months ago
NTRA, Eledon From Partnership For Prospera Use In Phase 3 Kidney Transplant Trial
Yahoo Finance • 4 months ago
Pre-Market Movers: TNGX, WOK, GOCO Set The Path
About
CEO | Dr. David-Alexandre C. Gros M.D., Ph.D. |
Address | 19800 MacArthur Boulevard, Irvine, CA, United States, 92612 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 33 |